stocks

Stocks jump after decline in oil, GDP revision

NEW YORK -- Stocks rose for the third straight session Thursday as oil prices fell sharply and the government reported that the economy grew last quarter at a faster pace than previously estimated.

Tech jump, oil drop lifts stocks; AMR skids late

NEW YORK (Reuters) - Stocks rose on Tuesday, led by Apple Inc (AAPL.O) and other technology bellwethers, as investors bet that a sharp drop in oil prices will help shore up consumer and business spending.

Wall Street buoyed by inflation report

The Dow rises 66 points despite a late sell-off of technology issues. Oil falls $1.58 to $124.22 a barrel. Stocks advanced Wednesday after a better-than-expected report on consumer prices tempered concerns about inflation.

7 Stocks at Bargain Prices

Whenever investors rush to the exits, stocks of good companies tend to get trampled along with the bad. And there has been quite a stampede out of stocks since last October. Between then and mid April, Standard & Poor's 500-stock index declined 15%; at one point, the benchmark was 18% below its peak.

Wall St dives on record oil over $123

NEW YORK (Reuters) - Stocks tumbled on Wednesday, on concerns about inflation and higher interest rates as oil jumped to a record above $123 a barrel.

Treasurys fall as investors gain more confidence in stocks

NEW YORK -- Treasury bond prices reversed course Tuesday, with investors pulling money out of government bonds to participate in a moderate rally in stocks.

Wall Street seen flat; techs, consumer sector in focus

LONDON (Reuters) - Stocks are likely to open steady on Tuesday, pausing after the previous session's sharp sell-off, with investors looking ahead to results from the technology, housing and consumer sectors.

Treasury prices decline as stock market rallies

NEW YORK -- Investors moved out of Treasury bonds on Thursday as a rally in stocks sent the Dow Jones industrials up nearly 190 points.

Wall Street ends lower on rate uncertainty

NEW YORK (Reuters) - Stocks fell on Wednesday after the Federal Reserve trimmed interest rates but left unclear the outlook for further rate cuts, prompting profit-taking as the Standard & Poor's 500 index ended its best month since December 2003.

Market wavers as drugs weigh; Citi down late

NEW YORK (Reuters) - Stocks ended little changed on Tuesday as setbacks for two drugs weighed down the pharmaceutical sector, offsetting the relief from a retreat in record high crude oil prices.

Syndicate content